Lethality of SARS‐CoV‐2 infection—a comparative autopsy study focusing on COVID‐19 development and virus variants

Different SARS‐CoV‐2 variants are driving various waves of infection of the corona pandemic. Official statistics provide no information on who died due to coronavirus disease 2019 (COVID‐19) or an alternative disease during which SARS‐CoV‐2 infection was detected. The current study aims at addressing the effect of the different variants evolving during the pandemic on fatal outcomes.

[1]  J. Joven,et al.  Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain , 2022, Scientific Reports.

[2]  É. Azoulay,et al.  ICU strain and outcome in COVID-19 patients—A multicenter retrospective observational study , 2022, PloS one.

[3]  S. Hoehl,et al.  Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies , 2022, eBioMedicine.

[4]  P. Horby,et al.  An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients , 2022, medRxiv.

[5]  Gheyath K Nasrallah,et al.  Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections , 2022, The New England journal of medicine.

[6]  K. Pyrć,et al.  Characterization of SARS-CoV-2 replication complex elongation and proofreading activity , 2022, Scientific reports.

[7]  K. Swanson,et al.  Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection , 2022, bioRxiv.

[8]  Lisa M. Domke,et al.  Cell tropism and viral clearance during SARS-CoV-2 lung infection , 2022, Pathology - Research and Practice.

[9]  S. A. Abdool Karim,et al.  Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study , 2022, The Lancet Global Health.

[10]  S. Fukushi,et al.  Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants , 2022, Med.

[11]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months , 2021, The New England journal of medicine.

[12]  L. Dölken,et al.  SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro , 2021, Frontiers in Cellular and Infection Microbiology.

[13]  J. Min,et al.  SARS-CoV-2 cell tropism and multiorgan infection , 2021, Cell discovery.

[14]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[15]  D. Brodie,et al.  Forty Postmortem Examinations in COVID-19 Patients , 2020, American journal of clinical pathology.

[16]  P. Schirmacher,et al.  The Pathology of Severe COVID-19-Related Lung Damage. , 2020, Deutsches Arzteblatt international.

[17]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[18]  R. Berisio,et al.  A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping , 2020, Cells.

[19]  P. Adab,et al.  Covid-19: risk factors for severe disease and death , 2020, BMJ.

[20]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[21]  J. Friemann,et al.  [Autopsy rates in Germany]. , 2017, Der Pathologe.

[22]  J. Friemann,et al.  Obduktionszahlen in Deutschland , 2017, Der Pathologe.

[23]  M. Humbert,et al.  Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.

[24]  W. Weichert,et al.  Who Is at Risk for Diagnostic Discrepancies? Comparison of Pre- and Postmortal Diagnoses in 1800 Patients of 3 Medical Decades in East and West Berlin , 2012, PloS one.

[25]  D. Rosen,et al.  Postmortem findings in eight cases of influenza A/H1N1 , 2010, Modern Pathology.

[26]  A. Ng,et al.  Diffuse large B-cell lymphoma. , 2007, Seminars in radiation oncology.

[27]  B. Funke,et al.  Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.

[28]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[29]  F. Sebening,et al.  [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.